Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
Google Scholar
Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl Cancer Cent. 4, 47–53 (2024).
Google Scholar
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Google Scholar
Cao, W., Chen, H. D., Yu, Y. W., Li, N. & Chen, W. Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. Med. J. 134, 783–791 (2021).
Google Scholar
Sun, K. et al. Cancer incidence and mortality across diverse geographical regions in China, 2024. Chin. J. Oncol. 48, 400–412 (2026).
Google Scholar
Zheng, R. et al. Cancer incidence and mortality in China, 2024. J. Natl Cancer Cent. https://doi.org/10.1016/j.jncc.2025.10.003 (2026).
Chen, W. et al. Annual report on status of cancer in China, 2010. Chin. J. Cancer Res. 26, 48–58 (2014).
Google Scholar
National Bureau of Statistics of China. China’s National Economic and Population Statistics in 2025 https://www.stats.gov.cn/english/PressRelease/202601/t20260119_1962328.html (2026).
Ferlay, J. et al. Global Cancer Observatory: Cancer Tomorrow (version 1.1) https://gco.iarc.who.int/tomorrow (2024).
State Council of China. The Healthy China 2030 Blueprint https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm (2016).
State Council of China. The Healthy China Initiative (2019-2030) https://www.nhc.gov.cn/guihuaxxs/c100133/201907/2a6ed52f1c264203b5351bdbbadd2da8.shtml (2019).
Tan, X., Liu, X. & Shao, H. Healthy China 2030: a vision for health care. Value Health Reg. Issues 12, 112–114 (2017).
Google Scholar
National Health Commission. Implementation Plan for the Cancer Prevention and Control Action (2023–2030) https://www.nhc.gov.cn/ylyjs/gzdt/202311/9b7882e607324bda8a8222d4fd39f2fd.shtml (2023).
Wei, W. et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 21, e342–e349 (2020).
Google Scholar
He, J. et al. Cancer Atlas in China. 74–96 (SinoMaps Press, 2019).
Ferlay, J. Cancer Today (Version 1.1) (Global Cancer Observatory, International Agency for Research on Cancer & World Health Organization, 2024); https://gco.iarc.who.int/today.
Webb, A. B. et al. Considerations for using potential surrogate endpoints in cancer screening trials. Lancet Oncol. 25, e183–e192 (2024).
Google Scholar
Zeng, H. et al. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. Lancet Public Health 6, e877–e887 (2021).
Google Scholar
Shan, T. et al. Disparities in stage at diagnosis for liver cancer in China. J. Natl Cancer Cent. 3, 7–13 (2023).
Google Scholar
Xie, D. et al. Overdiagnosis of lung cancer due to the introduction of low-dose computed tomography in average-risk populations in the people’s republic of China. J. Thorac. Oncol. 20, 884–896 (2025).
Google Scholar
Wang, C. et al. China protocol for early screening, precise diagnosis, and individualized treatment of lung cancer. Signal Transduct. Target. Ther. 10, 175 (2025).
Google Scholar
Sarfati, D., Blakely, T. & Pearce, N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int. J. Epidemiol. 39, 598–610 (2010).
Google Scholar
Zeng, H. et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6, e555–e567 (2018).
Google Scholar
Zeng, H. et al. Cancer survival statistics in China 2019-2021: a multicenter, population-based study. J. Natl Cancer Cent. 4, 203–213 (2024).
Google Scholar
Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA Cancer J. Clin. 76, e70043 (2026).
Google Scholar
Li, J. Y. et al. Atlas of cancer mortality in the People’s Republic of China. An aid for cancer control and research. Int. J. Epidemiol. 10, 127–133 (1981).
Google Scholar
Armstrong, B. The epidemiology of cancer in the Peoples Republic of China. Int. J. Epidemiol. 9, 305–315 (1980).
Google Scholar
Dong, Z. et al. A report of cancer high incidence scene in China. China Cancer 18, 4–9 (2009).
Xia, C. et al. Cancer screening in China: a steep road from evidence to implementation. Lancet Public Health 8, e996–e1005 (2023).
Google Scholar
Matsuda, T. & Inoue, M. Moving towards tailored, region-specific cancer-control measures in China. Lancet Glob. Health 7, e175–e176 (2019).
Google Scholar
Feng, R. et al. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun. 43, 75–86 (2023).
Google Scholar
Zhang, S. et al. Cancer incidence and mortality in China, 2015. J. Natl Cancer Cent. 1, 2–11 (2021).
Google Scholar
Moyer, V. A. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 160, 330–338 (2014).
Google Scholar
Xu, Y., Xia, C., Wang, J., Wu, Y. & Chen, W. Divergent trends in the burden of esophageal, gastric, and liver cancers in China. J. Natl Cancer Cent. 5, 306–312 (2025).
Google Scholar
Cui, F. et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg. Infect. Dis. 23, 765–772 (2017).
Google Scholar
Li, Y. et al. The global incident gastrointestinal cancers attributable to suboptimal diets from 1990 to 2018. Gastroenterology 167, 1141–1151 (2024).
Google Scholar
Song, Q. K. et al. Age of diagnosis of breast cancer in China: almost 10 years earlier than in the United States and the European Union. Asian Pac. J. Cancer Prev. 15, 10021–10025 (2014).
Google Scholar
Zahed, H. et al. Age at diagnosis for lung, colon, breast and prostate cancers: an international comparative study. Int. J. Cancer 154, 28–40 (2024).
Google Scholar
Wang, X. et al. Landscape of young breast cancer under 35 years in China over the past decades: a multicentre retrospective cohort study (YBCC-Catts study). EClinicalMedicine 64, 102243 (2023).
Google Scholar
Ang, B. H., Teo, S. H. & Ho, W. K. Systematic review and meta-analysis of lifestyle and reproductive factors associated with risk of breast cancer in Asian women. Cancer Epidemiol. Biomarkers Prev. 33, 1273–1285 (2024).
Google Scholar
Zhang, M. et al. Breast cancer screening coverage – China, 2018-2019. China CDC Wkly. 5, 321–326 (2023).
Google Scholar
Ma, S., Sun, K., Han, B., Zheng, R. & Wei, W. Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals. Cancer Biol. Med. 22, 1017–1035 (2025).
Google Scholar
Wei, F., Georges, D., Man, I., Baussano, I. & Clifford, G. M. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 404, 435–444 (2024).
Google Scholar
Malagón, T. et al. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study. Lancet Infect. Dis. 19, 317–326 (2019).
Google Scholar
Zhang, Y., Wang, X. & Pan, S. Prevalence and patterns of extramarital sex among Chinese men and women: 2000-2015. J. Sex Res. 58, 41–50 (2021).
Google Scholar
Zhang, M. et al. Cervical cancer screening rates among Chinese women – China, 2023-2024. China CDC Wkly. 7, 321–326 (2025).
Google Scholar
Pan, X. F., Li, R., Pan, A. & Larson, H. Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. Lancet Infect. Dis. 16, 1322–1323 (2016).
Google Scholar
Murphy, F. China adds HPV shot as first new immunisation programme vaccine in 17 years. BMJ 390, r1985 (2025).
Google Scholar
Xia, C. et al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health 4, 462–472 (2019).
Google Scholar
Li, M., Dal Maso, L., Pizzato, M. & Vaccarella, S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 12, 824–836 (2024).
Google Scholar
Li, M. et al. Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol. 9, 330–332 (2021).
Google Scholar
Wang, Z. et al. Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management. J Natl Cancer Cent. 5, 474–485 (2025).
Google Scholar
Zhu, Q. et al. Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022. Sci. China Life Sci. 68, 1478–1486 (2025).
Google Scholar
Ervik, M. et al. Cancer Over Time (Global Cancer Observatory, International Agency for Research on Cancer & World Health Organization, 2024); https://gco.iarc.who.int/overtime.
Park, E. H. et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2022. Cancer Res. Treat. 57, 312–330 (2025).
Google Scholar
National Office for Cancer Prevention and Control. National Cancer Control and Prevention Plan (1986–2000). China Cancer 9, 336–337 (2000).
Zhao, P., Dai, M., Chen, W. & Li, N. Cancer trends in China. Jpn. J. Clin. Oncol. 40, 281–285 (2010).
Google Scholar
Chen, W. et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob. Health 7, 257–269 (2019).
Google Scholar
Xia, C. et al. Provincial-level cancer burden attributable to active and second-hand smoking in China. Tob. Control 28, 669–675 (2019).
Google Scholar
Secretan, B. et al. A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 10, 1033–1034 (2009).
Google Scholar
Chan, K. H. et al. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study. Lancet Public Health 7, e1014–e1026 (2022).
Google Scholar
Zeng, X., Liu, S., Liu, Y. & Xiao, L. Smoking prevalence in urban and rural areas – China, 2024. China CDC Wkly. 7, 751–759 (2025).
Google Scholar
Chinese Center for Disease Control and Prevention. Main Results and Findings of the 2024 China Adult Tobacco Survey. https://www.chinacdc.cn/jksj/jksj04/202506/t20250616_307668.html (2025).
Sun, D., Pang, Y., Lyu, J. & Li, L. Current progress and challenges to tobacco control in China. China CDC Wkly. 4, 101–105 (2022).
Google Scholar
Chan, K. H., Xiao, D., Zhou, M., Peto, R. & Chen, Z. Tobacco control in China. Lancet Public Health 8, e1006–e1015 (2023).
Google Scholar
Bi, M., Xie, L., Xi, Z. & Yang, J. The current situation of subnational legislation on smoking ban in indoor public places, indoor workplaces, and public transport – China, 2024. China CDC Wkly. 7, 777–782 (2025).
Google Scholar
Millwood, I. Y. et al. Alcohol intake and cause-specific mortality: conventional and genetic evidence in a prospective cohort study of 512 000 adults in China. Lancet Public Health 8, e956–e967 (2023).
Google Scholar
Wei, P. et al. Alcohol drinking behavior among adults aged 18 and above in China. Food Nutr. China 27, 15–19 (2021).
Hu, A. et al. The transition of alcohol control in China 1990-2019: impacts and recommendations. Int. J. Drug Policy 105, 103698 (2022).
Google Scholar
Ji, N., Bai, Y., Xu, J., Liu, M. & Jia, A. Time to take actions to reduce the harmful use of alcohol in China. China CDC Wkly. 3, 74–77 (2021).
Google Scholar
World Cancer Research Fund/American Institute for Cancer Research. Cancer Prevention and Survival: Summary of Global Evidence on Diet, Weight, Physical Activity & What Increases or Decreases Your Risk of Cancer (World Cancer Research Fund/American Institute for Cancer Research, 2017).
Thompson, R. et al. Major new review of global evidence on diet, nutrition and physical activity: a blueprint to reduce cancer risk. Nutr. Bull. 43, 269–283 (2018).
Google Scholar
McTiernan, A. et al. Physical activity in cancer prevention and survival: a systematic review. Med. Sci. Sports Exerc. 51, 1252–1261 (2019).
Google Scholar
Zhang, M. et al. Trends in insufficient physical activity among adults in China 2010-18: a population-based study. Int. J. Behav. Nutr. Phys. Act. 20, 87 (2023).
Google Scholar
State Council of China. National Fitness Plan (2021–2025) https://www.gov.cn/zhengce/zhengceku/2021-08/03/content_5629218.htm (2021).
Lauby-Secretan, B. et al. Body fatness and cancer — viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794–798 (2016).
Google Scholar
Wang, L. et al. Cancer incidence in relation to body fatness among 0.5 million men and women: findings from the China Kadoorie Biobank. Int. J. Cancer 146, 987–998 (2020).
Google Scholar
Pan, X. F., Wang, L. & Pan, A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 9, 373–392 (2021).
Google Scholar
Ting, P. et al. Prevalence and inequalities of obesity and associated complications in China: a multicentre nationwide survey. Public Health 237, 97–106 (2024).
Google Scholar
National Health Commission. Healthy Weight Management Initiative https://www.nhc.gov.cn/guihuaxxs/c100133/202504/b5d296bc536e42aa95baead98e792c67.shtml (2025).
Sun, X. et al. Expert consensus and call on actions for weight management in China: advancing healthy China initiative through strategic actions. China CDC Wkly. 6, 1347–1353 (2024).
Google Scholar
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607 (2015).
Google Scholar
Chen, Y. et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia 60, 1022–1032 (2017).
Google Scholar
Wang, L. et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA 326, 2498–2506 (2021).
Google Scholar
National Health Commission. Diabetes Prevention and Control Initiative (2024-2030) https://www.nhc.gov.cn/ylyjs/gzdt/202407/330feafa9cd7458080c05dcdfd380af8.shtml (2024).
Chinese Nutrition Society. Dietary Guidelines for Chinese Residents (2022) (People’s Health Publishing House, 2022).
Wang, L. et al. Trends in fruit and vegetable intake among the labor force population – China, 2010-2018. China CDC Wkly. 6, 401–407 (2024).
Google Scholar
Zhu, Q. et al. Association between dietary fiber intake and hyperuricemia among Chinese adults: analysis of the China adult chronic disease and nutrition surveillance (2015). Nutrients 14, 1433 (2022).
Google Scholar
Yu, D., Zhao, L. & Zhao, W. Status and trends in consumption of grains and dietary fiber among Chinese adults (1982-2015). Nutr. Rev. 78, 43–53 (2020).
Google Scholar
Huang, F. et al. Dietary calcium intake and food sources among Chinese adults in CNTCS. PLoS ONE 13, e0205045 (2018).
Google Scholar
Dongmei, Y. et al. Intake of energy and major nutrients among Chinese residents, 2015-2017. Food Nutr. China 27, 5–10 (2021).
Du, H. et al. Red meat, poultry and fish consumption and risk of diabetes: a 9 year prospective cohort study of the China Kadoorie Biobank. Diabetologia 63, 767–779 (2020).
Google Scholar
Chang, Z. et al. Trajectories of nutritional quality, diet-related environmental impact, and diet cost in China: how much does ultra-processed food and drink consumption matter? Nutrients 17, 334 (2025).
Google Scholar
Zhuang, P. et al. Preserved vegetable consumption and its association with mortality among 440,415 people in the China Kadoorie Biobank. BMC Med. 21, 135 (2023).
Google Scholar
World Health Organization. Personal Habits and Indoor Combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100E (IARC Publications, 2012).
Guo, X. et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int. J. Cancer 124, 2942–2947 (2009).
Google Scholar
Baan, R. et al. A review of human carcinogens-part F: chemical agents and related occupations. Lancet Oncol. 10, 1143–1144 (2009).
Google Scholar
Chen, T., Liu, J., Li, Y. & Wei, S. Burden of disease associated with dietary exposure to aflatoxins in China in 2020. Nutrients 14, 1027 (2022).
Google Scholar
Ministry of Agriculture and Rural Affairs. The Food and Nutrition Development Guideline (2025-2030) https://www.moa.gov.cn/govpublic/KJJYS/202503/t20250317_6471803.htm (2025).
Bouvard, V. et al. A review of human carcinogens—part B: biological agents. Lancet Oncol. 10, 321–322 (2009).
Google Scholar
Pan, K. F. et al. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat. Med. 30, 3250–3260 (2024).
Google Scholar
Xie, L. et al. Prevalence of Helicobacter pylori infection in China from 2014-2023: a systematic review and meta-analysis. World J. Gastroenterol. 30, 4636–4656 (2024).
Google Scholar
Zhang, J. Interpretation of key points from the white paper on Helicobacter pylori infection prevention and control in China. Chin. J. Integr. Tradit. West. Med. Dig. 32, 279–282 (2024).
Google Scholar
Hui, Z. et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg. Health West. Pac. 51, 101193 (2024).
Google Scholar
National Health Commission Of The People’s Republic of China. Childhood immunization schedule for national immunization program vaccines – China (version 2021). China CDC Wkly. 3, 1101–1108 (2021).
Google Scholar
Li, J. et al. Seroepidemiology of hepatitis C virus infection in people aged 1-69 years in China: a national, cross-sectional study. Lancet Public Health 10, e1036–e1044 (2025).
Google Scholar
Li, J., Pang, L. & Liu, Z. Interpretation of the national action plan for eliminating hepatitis C as a public health threat (2021-2030). China CDC Wkly. 4, 627–630 (2022).
Google Scholar
National Center for AIDS/STD Control and Prevention of China CDC. National HIV/STD epidemic update, December 2025. Chin. J. AIDS STD 32, 253 (2026).
General Office of the State Council of the People’s Republic of China. China’s plan for HIV/AIDS prevention and control (2024–2030). J. Emerg. Infect. Dis. 10, 91–93 (2025).
Han, S. et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 23, 158 (2025).
Google Scholar
Ji, M. F. et al. Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat. Commun. 16, 5940 (2025).
Google Scholar
Wu, Z. et al. Research progress on nasopharyngeal carcinoma screening. Chin. J. Cell Biol. 47, 329–335 (2025).
Google Scholar
National Disease Control and Prevention Administration. National Comprehensive Prevention and Control Plan for Echinococcosis and Other Key Parasitic Diseases (2024–2030) https://www.ndcpa.gov.cn/jbkzzx/c100081/common/content/content_1788432040413999104.html (2024).
Qian, M. B. et al. Clonorchiasis in China: geospatial modeling of the population infected and at risk, based on national surveillance. J. Infect. 91, 106528 (2025).
Google Scholar
Zhang, T. et al. Human herpesvirus 8 seroprevalence, China. Emerg. Infect. Dis. 18, 150–152 (2012).
Google Scholar
El Ghissassi, F. et al. A review of human carcinogens—part D: radiation. Lancet Oncol. 10, 751–752 (2009).
Google Scholar
Loomis, D. et al. The carcinogenicity of outdoor air pollution. Lancet Oncol. 14, 1262–1263 (2013).
Google Scholar
Miao, X. et al. Indoor radon survey in 31 provincial capital cities and estimation of lung cancer risk in urban areas of China. Biomed. Environ. Sci. 37, 1294–1302 (2024).
Google Scholar
State Council of China. Carbon Peaking and Carbon Neutrality China’s Plans and Solutions https://english.www.gov.cn/archive/whitepaper/202511/08/content_WS690ee812c6d00ca5f9a076cd.html (2025).
Standardization Administration of China. Requirements for control of indoor radon and its progeny. Vol. GB/T 16146-2015, 1–6 (Standards Press of China, 2015).
Liu, C., Zhu, B., Ni, J. & Wei, C. Residential coal-switch policy in China: development, achievement, and challenge. Energy Policy 151, 112165 (2021).
Google Scholar
National Disease Control and Prevention Administration. Implementation Plan for the Healthy Environment Promotion Initiative (2025-2030) https://www.ndcpa.gov.cn/jbkzzx/c100014/common/content/content_1952335475719442432.html (2025).
Ministry of Ecology and Environment. The National Ecological Meteorological Bulletin (2024) https://www.mee.gov.cn/hjzl/sthjzk/zghjzkgb/ (2025).
Bai, T. Study on the use of sunscreen products based on the spatial and temporal distribution characteristics of UV index in China. Open J. Nat. Sci. 9, 985–1002 (2021).
Google Scholar
Wang, D. et al. History of the development of the reporting system of occupational diseases and occupational disease list in China. China CDC Wkly. 2, 314–318 (2020).
Google Scholar
Das, S. et al. Aristolochic acid-associated cancers: a public health risk in need of global action. Nat. Rev. Cancer 22, 576–591 (2022).
Google Scholar
Boffetta, P., Hecht, S., Gray, N., Gupta, P. & Straif, K. Smokeless tobacco and cancer. Lancet Oncol. 9, 667–675 (2008).
Google Scholar
Rumgay, H. et al. Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25, 1413–1423 (2024).
Google Scholar
Yu, C. et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann. Intern. Med. 168, 489–497 (2018).
Google Scholar
Zhang, J. et al. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial. JAMA Oncol. 7, 263–270 (2021).
Google Scholar
Shen, S. et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br. J. Cancer 112, 998–1004 (2015).
Google Scholar
Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395–409 (2011).
Google Scholar
Chen, R. et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 70, 251–260 (2021).
Google Scholar
Xia, C. et al. Effect of an endoscopy screening on upper gastrointestinal cancer mortality: a community-based multicenter cluster randomized clinical trial. Gastroenterology 168, 725–740 (2025).
Google Scholar
Zeng, H. et al. Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study. Nat. Cancer 4, 1382–1394 (2023).
Google Scholar
Bretthauer, M. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N. Engl. J. Med. 387, 1547–1556 (2022).
Google Scholar
Li, T. et al. Anti-Epstein-Barr virus BNLF2b for mass screening for nasopharyngeal cancer. N. Engl. J. Med. 389, 808–819 (2023).
Google Scholar
National Health Commission. Lung cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 911–912 (2024).
National Health Commission. Colorectal cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 917–918 (2024).
National Health Commission. Esophageal cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 913–914 (2024).
National Health Commission. Gastric cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 915–916 (2024).
He, J. et al. China guideline for liver cancer screening (2022, Beijing). Chin. J. Oncol. 44, 779–814 (2022).
National Health Commission. Breast Cancer and Cervical Cancer Screening Protocol https://www.nhc.gov.cn/fys/c100078/202201/e4209b0a6e604f6aba3e793d8eddebf3.shtml(2022).
Lin, C. & Chen, W. Overview of screening and early detection of primary malignant tumors in general population in China. Chin. J. Oncol. 47, 456–462 (2025).
Google Scholar
Tan, N. et al. Extending breast cancer screening beyond age 45-64 years in China: a cost-effectiveness analysis. Cancer Lett. 612, 217457 (2025).
Google Scholar
National Health Commission. Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030) https://www.nhc.gov.cn/fys/c100078/202301/001debf5e15f4da99d03aac3a803b2de.shtml (2023).
Cao, W. et al. Uptake of lung cancer screening with low-dose computed tomography in China: a multi-centre population-based study. EClinicalMedicine 52, 101594 (2022).
Google Scholar
Zhao, M. et al. Analysis of compliance and influencing factors of lung cancer screening among residents in Yangzhong City, Jiangsu Province from 2024 to 2025. China Cancer 35, 23–31 (2026).
Zhang, X., Fang, Y. & Pang, Y. Analysis of social screening results of lung cancer among rural residents in Shaanxi Province from 2020 to 2023. Chin. J. Soc. Med. 42, 188–191 (2025).
Chen, H. et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut 68, 1450–1457 (2019).
Google Scholar
Zheng, P., Lu, L., Zhu, F. & Dai, S. Analysis of colorectal cancer screening results in Yongjia County. J. Prev. Med. 34, 727–731 (2022).
Zhang, X. et al. Analysis of screening results and compliance of colorectal cancer among rural residents in Beijing, 2017-2021. China Cancer 32, 603–609 (2023).
Ma, J. et al. Colorectal cancer screening results and colonoscopy compliance among rural residents in Sichuan Province. Mod. Prev. Med. 52, 4332–4338 (2025).
Li, H. et al. Profiles and findings of population-based esophageal cancer screening with endoscopy in China: systematic review and meta-analysis. JMIR Public Health Surveill. 9, e45360 (2023).
Google Scholar
Chen, W., Li, N. & Cao, M. Preliminary analysis of cancer screening program in Urban China from 2013 to 2017. China Cancer 29, 1–6 (2020).
Xia, C. et al. Baseline results for the Cancer Screening Program in Huai River areas from 2007 to 2023. Chin. J. Prev. Control Chron. Dis. 33, 648–654 (2025).
Li, J. et al. Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal, stomach and liver cancer in China, 2010-2016. J. Natl Cancer Cent. 1, 101–107 (2021).
Google Scholar
Ma, L. et al. Breast ultrasound optimization process analysis based on breast cancer screening for 1,501,753 rural women in China. Chin. J. Oncol. 43, 497–503 (2021).
Google Scholar
Chen, W. J. et al. Impact of an Epstein-Barr virus serology-based screening program on nasopharyngeal carcinoma mortality: a cluster-randomized controlled trial. J. Clin. Oncol. 43, 22–31 (2025).
Google Scholar
Baccolini, V. et al. The association between adherence to cancer screening programs and health literacy: a systematic review and meta-analysis. Prev. Med. 155, 106927 (2022).
Google Scholar
Bai, Y., Wong, C. L., Peng, X., Choi, K. C. & So, W. K. W. Effectiveness of a tailored communication intervention on colonoscopy uptake for firstdegree relatives of colorectal cancer patients: a randomized controlled trial. Asia Pac. J. Oncol. Nurs. 9, 100068 (2022).
Google Scholar
World Health Organization. A Short Guide to Cancer Screening: Increase Effectiveness, Maximize Benefits and Minimize Harm (WHO, 2022).
Dong, Z. et al. The exploration of evaluating indicators for early detection and treatment of cancers in China. China Cancer 19, 633–638 (2010).
Jabbari, A., Najafpour, Z., Ourang, S. & Cheraghi, M. Developing and validating key performance indicators for breast, cervical, and colorectal cancer screening programs: a literature review and Delphi survey. Front. Public Health 13, 1491226 (2025).
Google Scholar
National Health Commission. Reply to the “Suggestions on Further Strengthening the Efforts of Cancer Prevention and Control in China” https://www.nhc.gov.cn/wjw/jiany/202409/24aab6de664a4bb0805951f3ac50a493.shtml (2024).
Zhi, X. Y. et al. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011). J. Thorac. Dis. 4, 88–101 (2012).
Google Scholar
Zhi, X. Y., Yu, J. M. & Shi, Y. K. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer 121, 3165–3181 (2015).
Google Scholar
National health Commission. Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version). Chin. J. Cancer Res. 31, 1–28 (2019).
Google Scholar
Health Commission Of The People’s Republic Of China. National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version). Chin. J. Cancer Res. 34, 176–206 (2022).
Google Scholar
Lu, Z. et al. The landscape of cancer research and cancer care in China. Nat. Med. 29, 3022–3032 (2023).
Google Scholar
Shao, L. et al. Regulatory watch: innovative drug availability in China. Nat. Rev. Drug Discov. 15, 739–740 (2016).
Google Scholar
Wang, F., Ruan, D. Y. & Xu, R. H. Challenges and opportunities in oncology drug development and clinical research in China. Cell 187, 1578–1583 (2024).
Google Scholar
Huang, H. et al. Growing research and development of targeted anticancer drugs in China. J. Natl Cancer Cent. 3, 129–134 (2023).
Google Scholar
Zhang, Y. et al. Overall survival benefits of cancer drugs approved in China from 2005 to 2020. JAMA Netw. Open 5, e2225973 (2022).
Google Scholar
Hanna, T. P. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371, m4087 (2020).
Google Scholar
Koo, M. M. et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 21, 73–79 (2020).
Google Scholar
Agbedinu, K. et al. A Scoping review on barriers to cancer diagnosis and care in low- and middle-income countries. Cancer Epidemiol. Biomarkers Prev. 34, 1066–1073 (2025).
Google Scholar
Bamodu, O. A. & Chung, C. C. Cancer care disparities: overcoming barriers to cancer control in low- and middle-income countries. JCO Glob. Oncol. 10, e2300439 (2024).
Google Scholar
Cai, Y. et al. Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008-2017. Chin. J. Cancer Res. 33, 627–636 (2021).
Google Scholar
Peng, N. et al. Systematic review of the impact of the National Medication Price Negotiated Policy on the accessibility of drugs in China, 2016-2024. BMJ Open 14, e087190 (2024).
Google Scholar
Zhou, J., Lan, T., Lu, H. & Pan, J. Price negotiation and pricing of anticancer drugs in China: an observational study. PLoS Med. 21, e1004332 (2024).
Google Scholar
Gruber, J., Lin, M., Yang, H. & Yi, J. China’s social health insurance in the era of rapid population aging. JAMA Health Forum 6, e251105 (2025).
Google Scholar
Li, W. et al. Access to innovative anticancer medicines in China: a national survey on availability, price and affordability. BMJ Open 14, e077089 (2024).
Google Scholar
Cao, W., Qin, K., Liu, B. & Chen, W. Cancer statistics in China: epidemiology, risk factors, and prevention. Chin. J. Cancer Res. 37, 912–928 (2025).
Google Scholar
He, S. et al. Geographic, demographic, and socioeconomic disparities and factors associated with cancer literacy in China: national cross-sectional study. JMIR Public Health Surveill. 9, e43541 (2023).
Google Scholar
Lin, Y. et al. Diagnostic routes and symptom-to-treatment delays in gastric cancer: findings from a cross-sectional study in southeastern China. Public Health 248, 105934 (2025).
Google Scholar
Xing, W. et al. Understanding and mitigating cancer-related financial toxicity in China: challenges and recommendations. Lancet Reg. Health West. Pac. 60, 101601 (2025).
Google Scholar
Wang, Y. et al. Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey. Holist. Integr. Oncol. 3, 51 (2024).
Google Scholar
Song, J. et al. Current status of and future perspectives on care for cancer survivors in China. Glob. Health Med. 5, 208–215 (2023).
Google Scholar
Zhou, Y. et al. Universal health coverage in China: a serial national cross-sectional study of surveys from 2003 to 2018. Lancet Public Health 7, e1051–e1063 (2022).
Google Scholar
Zhang, Y. et al. Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis. Lancet Oncol. 26, 1252–1260 (2025).
Google Scholar
Huang, H. et al. Accelerating the integration of China into the global development of innovative anticancer drugs. Lancet Oncol. 23, e515–e520 (2022).
Google Scholar
Wang, X. et al. People-centred integrated care in urban China. Bull. World Health Organ. 96, 843–852 (2018).
Google Scholar
Dong, W. et al. Effect of the national integrated demonstration area for the prevention and control of noncommunicable diseases programme on behavioural risk factors in China: a synthetic difference-in-differences study. Lancet Reg. Health West. Pac. 50, 101167 (2024).
Google Scholar
Xu, T. Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China. Chin. J. Cancer Res. 27, 423–427 (2015).
Google Scholar
